Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.
Ignace VergoteEls Van NieuwenhuysenRoisin E O'CearbhaillAnneke M WestermannDomenica LorussoSharad GhamandeDearbhaile C CollinsSusana BanerjeeCara A MathewsChristine GennigensDavid CibulaKrishnansu S TewariKristine MadsenFatih KöseAmanda L JacksonIngrid A BoereGiovanni ScambiaLeslie M RandallAzmat SadozyeJean-François BaurainEelke H GortMichal ZikánHannelore G DenysPetronella B OttevangerFrédéric ForgetCamilla Mondrup AndreassenLamar EatonMichael J ChisamoreLeonardo Viana NicacioIbrahima SoumaoroBradley J MonkPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
TV in combination with bevacizumab, carboplatin, or pembrolizumab demonstrated manageable safety and encouraging antitumor activity in treatment-naive and previously treated r/mCC.